Total Funding
54
46
Total FundingPost-IPO Equity raised
Growth Score
-8 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
88294
BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.
- Holly May: Chief Commercial OfficerPast Role: Avrobio, Chief Commercial Officer (CCO)
- PHILIP A. SERLIN: Chief Executive Officer
About the Company
BioLineRx is a clinical-stage, publicly traded (NASDAQ/ TASE: BLRX) biopharmaceutical development company based in Jerusalem, Israel. The Company develops products suitable for the pharmaceutical market satisfying an unmet medical need or exhibiting advantages over current therapies.
